High dosage of Exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells

Acta Pharmacol Sin. 2010 May;31(5):570-7. doi: 10.1038/aps.2010.38. Epub 2010 Apr 26.

Abstract

Aim: To investigate early insulin release (EIR) and late insulin release (LIR) upon glucose challenge as well as important insulin signaling factors in differentiated insulin-producing cells from embryonic stem cells(ESCs).

Methods: A recently published protocol was modified by increasing the concentration of Exendin-4 (from 0.1 nmol/L to 10 nmol/L) together with an additional 5-day culture in low glucose (5.5 mmol/L) medium after differentiation. Gene expression profile, insulin content, C-peptide, EIR and LIR were determined.

Results: Compared to a lower concentration of Exendin-4 (0.1 nmol/L), a higher concentration of Exendin-4 (10 nmol/L) increased glucose-responsive insulin secretion, especially EIR. Moreover, 10 nmol/L Exendin-4 increased the expression of the following genes: insulin 1, Pdx-1 (an important transcription factor, newly recognized insulin signaling factors), Epac1 and Epac2 (exchange proteins directly activated by cAMP 1 and 2), and sulfonylurea receptor 1 (SUR1, the subunit of the K(ATP) channel).

Conclusion: According to current knowledge, our modified protocol with a higher concentration of Exendin-4 (10 nmol/L) together with an additional 5-day 5.5 mmol/L glucose culture after differentiation improved the efficiency of differentiation toward the beta cell phenotype, which was possibly the result of stimulated expression of Pdx-1, Epac 1, and Epac 2, which in turn inhibited the K(ATP) channel through combination with SUR1, leading to increased EIR upon glucose challenge.

MeSH terms

  • Animals
  • C-Peptide / metabolism
  • Cell Differentiation
  • Cells, Cultured
  • Embryonic Stem Cells / cytology*
  • Exenatide
  • Gene Expression Profiling
  • Glucose / metabolism
  • Hypoglycemic Agents / pharmacology*
  • Insulin / metabolism*
  • Insulin-Secreting Cells / cytology
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism*
  • Mice
  • Peptides / pharmacology*
  • Phenotype
  • Venoms / pharmacology*

Substances

  • C-Peptide
  • Hypoglycemic Agents
  • Insulin
  • Peptides
  • Venoms
  • Exenatide
  • Glucose